Avaí Bio Completes Cell Bank Testing, Advances ?-Klotho Anti-Aging Therapy

Avaí Bio announced successful completion of comprehensive adventitious-agent and viral testing for its GMP Master Cell Bank, a manufacturing-quality milestone for its cell-based therapy pipeline targeting diabetes, age-related disorders and anti-aging. The announcement supports development readiness, but the provided text contains no clinical efficacy, regulatory approval, revenue or financial guidance details.